Abstract:Purpose: AI modeling physicians' clinical decision-making (CDM) can improve the efficiency and accuracy of clinical practice or serve as a surrogate to provide initial consultations to patients seeking secondary opinions. In this study, we developed an interpretable AI model that predicts dose fractionation for patients receiving radiation therapy for brain metastases with an interpretation of its decision-making process. Materials/methods: 152 patients with brain metastases treated by radiosurgery from 2017 to 2021 were obtained. CT images and target and organ-at-risk (OAR) contours were extracted. Eight non-image clinical parameters were also extracted and digitized, including age, the number of brain metastasis, ECOG performance status, presence of symptoms, sequencing with surgery (pre- or post-operative radiation therapy), de novo vs. re-treatment, primary cancer type, and metastasis to other sites. 3D convolutional neural networks (CNN) architectures with encoding paths were built based on the CT data and clinical parameters to capture three inputs: (1) Tumor size, shape, and location; (2) The spatial relationship between tumors and OARs; (3) The clinical parameters. The models fuse the features extracted from these three inputs at the decision-making level to learn the input independently to predict dose prescription. Models with different independent paths were developed, including models combining two independent paths (IM-2), three independent paths (IM-3), and ten independent paths (IM-10) at the decision-making level. A class activation score and relative weighting were calculated for each input path during the model prediction to represent the role of each input in the decision-making process, providing an interpretation of the model prediction. The actual prescription in the record was used as ground truth for model training. The model performance was assessed by 19-fold cross-validation, with each fold consisting of randomly selected 128 training, 16 validation, and 8 testing subjects. Result: The dose prescriptions of 152 patient cases included 48 cases with 1 × 24 Gy, 48 cases with 1 × 20-22 Gy, 32 cases with 3 × 9 Gy, and 24 cases with 5 × 6 Gy prescribed by 8 physicians. IM-2 achieved slightly superior performance than IM-3 and IM-10, with 131 (86%) patients classified correctly and 21 (14%) patients misclassified. IM-10 provided the most interpretability with a relative weighting for each input: target (34%), the relationship between target and OAR (35%), ECOG (6%), re-treatment (6%), metastasis to other sites (6%), number of brain metastases (3%), symptomatic (3%), pre/post-surgery (3%), primary cancer type (2%), age (2%), reflecting the importance of the inputs in decision making. The importance ranking of inputs interpreted from the model also matched closely with a physician's own ranking in the decision process. Conclusion: Interpretable CNN models were successfully developed to use CT images and non-image clinical parameters to predict dose prescriptions for brain metastases patients treated by radiosurgery. Models showed high prediction accuracy while providing an interpretation of the decision process, which was validated by the physician. Such interpretability makes the model more transparent, which is crucial for the future clinical adoption of the models in routine practice for CDM assistance.

AI-assisted Clinical Decision Making (CDM) for Dose Prescription in Radiosurgery of Brain Metastases Using Three-Path Three-Dimensional CNN

Interpretable AI-assisted clinical decision making (CDM) for dose prescription in radiosurgery of brain metastases

Automated Clinical Target Volume Delineation Using Deep 3D Neural Networks in Radiation Therapy of Non-small Cell Lung Cancer

Dosimetric Analysis of Radiation Treatment Plans Based on a Deep Learning Auto Contouring Model for Patients with Localized Prostate Cancer

Development and Validation of a Fully Automatic Tissue Delineation Model for Brain Metastasis Using a Deep Neural Network.

Three-dimensional dose prediction based on deep convolutional neural networks for brain cancer in CyberKnife: accurate beam modelling of homogeneous tissue

Deep-learning-driven Dose Prediction and Verification for Stereotactic Radiosurgical Treatment of Isolated Brain Metastases

Enhanced 3D dose prediction for hypofractionated SRS (gamma knife radiosurgery) in brain tumor using cascaded-deep-supervised convolutional neural network

Technical Note: A feasibility study on deep learning-based radiotherapy dose calculation

AS-NeSt: a Novel 3D Deep Learning Model for Radiotherapy Dose Distribution Prediction on Esophageal Cancer Treatment with Multiple Prescriptions

Breast radiotherapy planning: A decision‐making framework using deep learning

Cbct-Guided Prostate Adaptive Radiotherapy With Cbct-Based Synthetic Mri And Ct

Automatic Treatment Planning Based on Three-Dimensional Dose Distribution Predicted from Deep Learning Technique.

NIMG-01. PREDICTING POST-STEREOTACTIC RADIOTHERAPY MAGNETIC RESONANCE IMAGE OUTCOMES OF BREAST CANCER METASTASES TO THE BRAIN

AI Evaluation of Imaging Factors in the Evolution of Stage-Treated Metastases Using Gamma Knife

A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS)

Dose Evaluation of MRI-based Synthetic CT Generated Using a Machine Learning Method for Prostate Cancer Radiotherapy.

Boosting radiotherapy dose calculation accuracy with deep learning

A Feasibility Study on Deep Learning-Based Radiotherapy Dose Calculation

Fast Monte Carlo dose calculation based on deep learning

AS-NeSt: A Novel 3D Deep Learning Model for Radiation Therapy Dose Distribution Prediction in Esophageal Cancer Treatment with Multiple Prescriptions